Xenetic Biosciences logo

Xenetic Biosciences

XBIO | NASDAQ
Chart Builder DCF Calculator
$1.49
-$0.17 (-10.24%)
At close: Nov 16, 2026, 4:00 PM ET
$1.60
+$0.11 (+7.72%)
After-hours: Nov 16, 2026, 7:30 PM ET
-10.24%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #961/1021 (Top 94%)

Key Statistics

Market Data

Market Cap $3.49M
1D Range
1.43 1.75
52W Range
1.43 4.67

Valuation (TTM)

PE -0.94
PB 0.79
EV/EBITDA 0.63

Valuation (NTM)

Forward PE N/A
Forward PEG -0.02
Price Target $0.00
Loading financial charts...

Profile

Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T cell (CAR T) platform is...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Jun 30, 2016
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.